Amelia Evoli
Overview
Explore the profile of Amelia Evoli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
3320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Falso S, Zara P, Marini S, Puci M, Sabatelli E, Sotgiu G, et al.
J Neuroimmunol
. 2025 Jan;
399:578524.
PMID: 39799766
Introduction: Environmental factors may contribute to myasthenia gravis (MG) development, sometimes with seasonal patterns of exposure. However, whether seasonality has an impact on MG incidence remains unclear. We aimed to...
2.
Evoli A, Palace J, Spagni G, Cheli M, Ruiter A, Verschuuren J, et al.
Neuromuscul Disord
. 2024 Oct;
44:104468.
PMID: 39427494
The 275th ENMC workshop on the diagnosis and management of seronegative myasthenia gravis (SNMG) was held on February 9-11, 2024. The participants included experts in the field of adult and...
3.
Spagni G, Vincent A, Sun B, Falso S, Jacobson L, Devenish S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Sep;
11(6):e200313.
PMID: 39250722
Background And Objectives: In this retrospective longitudinal study, we aimed at exploring the role of (a) MuSK-immunoglobulin G (IgG) levels, (b) predominant MuSK-IgG subclasses, and (c) antibody affinity as candidate...
4.
Falso S, Marini S, Carrozza C, Sabatelli E, Mascagna G, Marini M, et al.
Eur J Neurol
. 2024 Aug;
31(12):e16435.
PMID: 39118440
Background And Purpose: Acetylcholine receptor antibody (AChR-Ab) detection is crucial in myasthenia gravis (MG) diagnosis and, currently, the radioimmunoassay (RIA) is the gold standard. However, RIA may detect AChR-Ab against...
5.
Falso S, Gessi M, Marini S, Benvenuto R, Sabatelli E, dAmati A, et al.
Ann Neurol
. 2024 Jul;
96(5):1020-1025.
PMID: 39007444
Cancer frequency in muscle-specific kinase myasthenia gravis (MuSK-MG) has not yet been explored and the mechanisms leading to the formation of MuSK IgG remain elusive. We aimed to explore cancer...
6.
Mantegazza R, Sacca F, Antonini G, Bonifati D, Evoli A, Habetswallner F, et al.
Neurol Sci
. 2024 Jul;
45(12):5671-5683.
PMID: 38967883
Myasthenia gravis (MG) is a rare, autoimmune, neurological disorder. Most MG patients have autoantibodies against acetylcholine receptors (AChRs). Some have autoantibodies against muscle-specific tyrosine kinase (MuSK) or lipoprotein-receptor-related protein 4...
7.
Cao M, Liu W, Maxwell S, Huda S, Webster R, Evoli A, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Aug;
10(6).
PMID: 37582613
Background And Objectives: Up to 50% of patients with myasthenia gravis (MG) without acetylcholine receptor antibodies (AChR-Abs) have antibodies to muscle-specific kinase (MuSK). Most MuSK antibodies (MuSK-Abs) are IgG4 and...
8.
Falso S, Spagni G, Iorio R, Evoli A
Neuromuscul Disord
. 2023 Jul;
33(9):90-92.
PMID: 37507235
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neuromuscular junction disorder, paraneoplastic in 55% of cases and commonly associated with small-cell lung cancer (SCLC). We report the case of a 61-year-old...
9.
Spagni G, Modoni A, Primiano G, Luigetti M, Sun B, Falso S, et al.
Neuromuscul Disord
. 2023 Jul;
33(8):636-642.
PMID: 37422355
Neuromyotonia and cramp-fasciculation syndrome diagnosis currently relies on neurophysiological examination. In this study we investigated the clinical features and neural antibody profile of patients with neuromyotonia and cramp-fasciculation syndrome to...
10.
Brascia D, Lucchi M, Aprile V, Guida M, Ricciardi R, Rea F, et al.
Eur J Cardiothorac Surg
. 2023 May;
63(5).
PMID: 37162377
Objectives: Total thymectomy in addition to medical treatment is an accepted standard therapy for myasthenia gravis (MG). Patients with severe generalized MG present life-threatening events, poor prognosis and higher risk...